These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 37385561

  • 1. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
    Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M.
    Int J Antimicrob Agents; 2023 Sep; 62(3):106905. PubMed ID: 37385561
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
    Raz-Pasteur A, Shasha D, Paul M.
    Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
    [Abstract] [Full Text] [Related]

  • 3. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR.
    Am J Ther; 2020 Sep; 27(2):e177-e182. PubMed ID: 30418221
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG.
    JAMA Pediatr; 2017 Dec 01; 171(12):1184-1191. PubMed ID: 29084336
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Vardakas KZ, Trigkidis KK, Falagas ME.
    Clin Microbiol Infect; 2017 Apr 01; 23(4):234-241. PubMed ID: 27965070
    [Abstract] [Full Text] [Related]

  • 6. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
    Al Saeedy D, Gillani SW, Al-Salloum J, Moosvi A, Eissa M, Gulam SM.
    Curr Pediatr Rev; 2020 Apr 01; 16(4):307-313. PubMed ID: 32895041
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
    Reeves SD, Hartmann AP, Tedder AC, Juang PA, Hofer M, Kollef MH, Micek ST, Betthauser KD.
    Clin Ther; 2024 Apr 01; 46(4):338-344. PubMed ID: 38403509
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic treatment strategies for community-acquired pneumonia in adults.
    Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ, CAP-START Study Group.
    N Engl J Med; 2015 Apr 02; 372(14):1312-23. PubMed ID: 25830421
    [Abstract] [Full Text] [Related]

  • 9. Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired Pneumonia.
    Kolditz M, Halank M, Höffken G.
    Treat Respir Med; 2006 Apr 02; 5(6):371-83. PubMed ID: 17154666
    [Abstract] [Full Text] [Related]

  • 10. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
    Lee JH, Kim HJ, Kim YH.
    J Korean Med Sci; 2017 Jan 02; 32(1):77-84. PubMed ID: 27914135
    [Abstract] [Full Text] [Related]

  • 11. Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward?
    Ruhe J, Mildvan D.
    Infect Dis Clin North Am; 2013 Mar 02; 27(1):115-32. PubMed ID: 23398869
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
    Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM.
    Crit Care Med; 2012 Aug 02; 40(8):2310-4. PubMed ID: 22622401
    [Abstract] [Full Text] [Related]

  • 13. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
    Garin N, Genné D, Carballo S, Chuard C, Eich G, Hugli O, Lamy O, Nendaz M, Petignat PA, Perneger T, Rutschmann O, Seravalli L, Harbarth S, Perrier A.
    JAMA Intern Med; 2014 Dec 02; 174(12):1894-901. PubMed ID: 25286173
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
    van Werkhoven CH, Postma DF, Mangen MJ, Oosterheert JJ, Bonten MJ, CAP-START study group.
    BMC Infect Dis; 2017 Jan 10; 17(1):52. PubMed ID: 28068956
    [Abstract] [Full Text] [Related]

  • 15. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.
    BMC Infect Dis; 2019 Jan 07; 19(1):17. PubMed ID: 30612559
    [Abstract] [Full Text] [Related]

  • 16. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
    Eljaaly K, Alshehri S, Aljabri A, Abraham I, Al Mohajer M, Kalil AC, Nix DE.
    BMC Infect Dis; 2017 Jun 02; 17(1):385. PubMed ID: 28576117
    [Abstract] [Full Text] [Related]

  • 17. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
    Lodise TP, Kwa A, Cosler L, Gupta R, Smith RP.
    Antimicrob Agents Chemother; 2007 Nov 02; 51(11):3977-82. PubMed ID: 17709460
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR, Lemonovich TL.
    Am Fam Physician; 2011 Jun 01; 83(11):1299-306. PubMed ID: 21661712
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
    Ambroggio L, Taylor JA, Tabb LP, Newschaffer CJ, Evans AA, Shah SS.
    J Pediatr; 2012 Dec 01; 161(6):1097-103. PubMed ID: 22901738
    [Abstract] [Full Text] [Related]

  • 20. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
    Lee MG, Lee SH, Chang SS, Chan YL, Pang L, Hsu SM, Lee CC.
    Medicine (Baltimore); 2015 Sep 01; 94(39):e1662. PubMed ID: 26426664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.